HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old

被引:44
作者
Carneiro, M
Fuller, C
Doherty, MC
Vlahov, D
机构
[1] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil
关键词
substance abuse; intravenous; human immunodeficiency virus;
D O I
10.1016/S0376-8716(98)00142-2
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Injection drug users (IDUs) who have recently initiated an injecting career have high risk behaviors for HIV infection. The average age of an IDUs first injection is typically reported as 19-20 years, and some literature has reported 'maturing out' of drug use typically around 40 years old. The purpose of this study was to discriminate risk behaviors among newer injectors by age of initiation. This cross-sectional study includes volunteers enrolled using extensive community recruitment techniques in 1988 and 1989 in Baltimore, MD. Of the 722 injection drug users who had initiated injection within the prior six years, 124 were over 35 years old of whom 53 were 40 years and older. Rates of HIV were lower among those over 40 years (13.2%) than those who were 35-39 years (22.5%) or under 35 pears old (20.9%). The behavioral characteristics of those aged 35-39 were similar to those under 35 years old, but those over 40 years old when compared with less than 39 years reported injecting at least daily less frequently (88.7% vs 76.5%, p = 0.042), using a needle from a sterile wrapper (19.0% vs 36.6%, p = 0.006), and injecting with their own works (52.6% vs 28.8%, p = 0.021). This study shows that people initiate injection drug use across a wide age range and that needle hygiene practices early after initiation tend to be safer in older compared to younger initiates. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:83 / 86
页数:4
相关论文
共 15 条
  • [1] HUMAN IMMUNODEFICIENCY VIRUS-INFECTION IN HETEROSEXUAL INTRAVENOUS-DRUG-USERS IN SAN-FRANCISCO
    CHAISSON, RE
    MOSS, AR
    ONISHI, R
    OSMOND, D
    CARLSON, JR
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1987, 77 (02) : 169 - 172
  • [2] DESJARLAIS DC, 1998, 12 WORLD AIDS C GEN
  • [3] AIDS AND THE NEW DRUG INJECTOR
    FRIEDMAN, SR
    DESJARLAIS, DC
    NEAIGUS, A
    ABDULQUADER, A
    SOTHERAN, JL
    SUFIAN, M
    TROSS, S
    GOLDSMITH, D
    [J]. NATURE, 1989, 339 (6223) : 333 - 334
  • [4] Frischer M, 1997, ADDICTION, V92, P419, DOI 10.1046/j.1360-0443.1997.9244196.x
  • [5] Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses
    Garfein, RS
    Vlahov, D
    Galai, N
    Doherty, MC
    Nelson, KE
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (05) : 655 - 661
  • [6] SEX-DIFFERENCES IN ADDICT CAREERS .1. INITIATION OF USE
    HSER, YI
    ANGLIN, MD
    MCGLOTHLIN, W
    [J]. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 1987, 13 (1-2) : 33 - 57
  • [7] MARMOR M, 1987, AIDS, V1, P39
  • [8] ISSUES IN THE TREATMENT OF HEROIN-ADDICTED WOMEN - A COMPARISON OF MEN AND WOMEN ENTERING 2 TYPES OF DRUG-ABUSE PROGRAMS
    MOISE, R
    REED, BG
    RYAN, V
    [J]. INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1982, 17 (01): : 109 - 139
  • [9] TEMPORAL TRENDS OF INCIDENT HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN A COHORT OF INJECTING DRUG-USERS IN BALTIMORE, MD
    NELSON, KE
    VLAHOV, D
    SOLOMON, L
    COHN, S
    MUNOZ, A
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (12) : 1305 - 1311
  • [10] PARENTERAL AND SEXUAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN INTRAVENOUS-DRUG-USERS - A STUDY OF SEROCONVERSION
    NICOLOSI, A
    LEITE, MLC
    MUSICCO, M
    MOLINARI, S
    LAZZARIN, A
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (03) : 225 - 233